- Home
- THCH vs IXHL Comparison
THCH vs IXHL Comparison
Compare THCH & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THCH
- IXHL
- Stock Information
- Founded
- THCH 2018
- IXHL 2001
- Country
- THCH China
- IXHL Australia
- Employees
- THCH N/A
- IXHL N/A
- Industry
- THCH Blank Checks
- IXHL
- Sector
- THCH Finance
- IXHL
- Exchange
- THCH Nasdaq
- IXHL Nasdaq
- Market Cap
- THCH 84.8M
- IXHL 78.7M
- IPO Year
- THCH N/A
- IXHL N/A
- Fundamental
- Price
- THCH $2.94
- IXHL $1.05
- Analyst Decision
- THCH
- IXHL
- Analyst Count
- THCH 0
- IXHL 0
- Target Price
- THCH N/A
- IXHL N/A
- AVG Volume (30 Days)
- THCH 7.8K
- IXHL 163.1M
- Earning Date
- THCH 08-28-2025
- IXHL 05-15-2025
- Dividend Yield
- THCH N/A
- IXHL N/A
- EPS Growth
- THCH N/A
- IXHL N/A
- EPS
- THCH N/A
- IXHL N/A
- Revenue
- THCH $187,384,526.00
- IXHL $98,000.00
- Revenue This Year
- THCH N/A
- IXHL $2,538.49
- Revenue Next Year
- THCH N/A
- IXHL $249.95
- P/E Ratio
- THCH N/A
- IXHL N/A
- Revenue Growth
- THCH N/A
- IXHL N/A
- 52 Week Low
- THCH $2.15
- IXHL $0.08
- 52 Week High
- THCH $5.15
- IXHL $3.12
- Technical
- Relative Strength Index (RSI)
- THCH 54.80
- IXHL 65.21
- Support Level
- THCH $2.84
- IXHL $0.21
- Resistance Level
- THCH $2.95
- IXHL $1.66
- Average True Range (ATR)
- THCH 0.09
- IXHL 0.15
- MACD
- THCH -0.01
- IXHL 0.11
- Stochastic Oscillator
- THCH 54.84
- IXHL 57.99
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.